The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up-Reference-Cited by-同舟云学术

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

Published:2003-03 Issue:3 Volume:39 Page:303-313
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bremnes Roy M,Sundstrom Stein,Aasebø Ulf,Kaasa Stein,Hatlevoll Reidulv,Aamdal Steinar

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference44 articles.

1. Cancer statistics, 2000;Greenlee;CA Cancer J. Clin.,2000

2. Management of small cell lung cancer. Current state of the art;Johnson;Chest,1999

3. Current management of small cell lung cancer;Sandler;Semin. Oncol.,1997

4. New chemotherapy agents for small cell lung cancer;Kelly;Chest,2000

5. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer;Ettinger;Semin. Radiat. Oncol.,1999

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chirurgie beim kleinzelligen Lungenkarzinom;Die Onkologie;2024-07-09

2. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-07

3. Temporal Stability and Prognostic Power of Radiomic Features for Survival Analysis in Lung Adenocarcinoma;Traitement du Signal;2023-12-30

4. Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada;Frontiers in Oncology;2023-12-06

5. Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide;Lung Cancer;2023-12